Cargando…

Association between the HTR2C rs1414334 C/G gene polymorphism and the development of the metabolic syndrome in patients treated with atypical antipsychotics

Few studies have assessed the association between the rs1414334 C/G polymorphism in the HTR2C gene and the development of the metabolic syndrome in patients treated with atypical antipsychotics. To provide further evidence, a cross-sectional study was conducted in Spain between 2012 and 2013 in 166...

Descripción completa

Detalles Bibliográficos
Autores principales: Rico-Gomis, José María, Palazón-Bru, Antonio, Triano-García, Irene, Mahecha-García, Luis Fabián, García-Monsalve, Ana, Navarro-Ruiz, Andrés, Villagordo-Peñalver, Berta, Jiménez-Abril, Jessica, Martínez-Hortelano, Alicia, Gil-Guillén, Vicente Francisco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: PeerJ Inc. 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4941738/
https://www.ncbi.nlm.nih.gov/pubmed/27441116
http://dx.doi.org/10.7717/peerj.2163
_version_ 1782442343402569728
author Rico-Gomis, José María
Palazón-Bru, Antonio
Triano-García, Irene
Mahecha-García, Luis Fabián
García-Monsalve, Ana
Navarro-Ruiz, Andrés
Villagordo-Peñalver, Berta
Jiménez-Abril, Jessica
Martínez-Hortelano, Alicia
Gil-Guillén, Vicente Francisco
author_facet Rico-Gomis, José María
Palazón-Bru, Antonio
Triano-García, Irene
Mahecha-García, Luis Fabián
García-Monsalve, Ana
Navarro-Ruiz, Andrés
Villagordo-Peñalver, Berta
Jiménez-Abril, Jessica
Martínez-Hortelano, Alicia
Gil-Guillén, Vicente Francisco
author_sort Rico-Gomis, José María
collection PubMed
description Few studies have assessed the association between the rs1414334 C/G polymorphism in the HTR2C gene and the development of the metabolic syndrome in patients treated with atypical antipsychotics. To provide further evidence, a cross-sectional study was conducted in Spain between 2012 and 2013 in 166 patients with these characteristics. In these patients, the association between the polymorphism and the presence of the metabolic syndrome was determined by implementing binary logistic regression models adjusted for variables associated with the metabolic syndrome. We did not confirm previous claims that the C allele of the polymorphism was linked to the metabolic syndrome: the association was in the opposite direction and non-significant. This conclusion held after taking gender and lifestyle variables into account.
format Online
Article
Text
id pubmed-4941738
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher PeerJ Inc.
record_format MEDLINE/PubMed
spelling pubmed-49417382016-07-20 Association between the HTR2C rs1414334 C/G gene polymorphism and the development of the metabolic syndrome in patients treated with atypical antipsychotics Rico-Gomis, José María Palazón-Bru, Antonio Triano-García, Irene Mahecha-García, Luis Fabián García-Monsalve, Ana Navarro-Ruiz, Andrés Villagordo-Peñalver, Berta Jiménez-Abril, Jessica Martínez-Hortelano, Alicia Gil-Guillén, Vicente Francisco PeerJ Diabetes and Endocrinology Few studies have assessed the association between the rs1414334 C/G polymorphism in the HTR2C gene and the development of the metabolic syndrome in patients treated with atypical antipsychotics. To provide further evidence, a cross-sectional study was conducted in Spain between 2012 and 2013 in 166 patients with these characteristics. In these patients, the association between the polymorphism and the presence of the metabolic syndrome was determined by implementing binary logistic regression models adjusted for variables associated with the metabolic syndrome. We did not confirm previous claims that the C allele of the polymorphism was linked to the metabolic syndrome: the association was in the opposite direction and non-significant. This conclusion held after taking gender and lifestyle variables into account. PeerJ Inc. 2016-07-07 /pmc/articles/PMC4941738/ /pubmed/27441116 http://dx.doi.org/10.7717/peerj.2163 Text en ©2016 Rico-Gomis et al. http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, reproduction and adaptation in any medium and for any purpose provided that it is properly attributed. For attribution, the original author(s), title, publication source (PeerJ) and either DOI or URL of the article must be cited.
spellingShingle Diabetes and Endocrinology
Rico-Gomis, José María
Palazón-Bru, Antonio
Triano-García, Irene
Mahecha-García, Luis Fabián
García-Monsalve, Ana
Navarro-Ruiz, Andrés
Villagordo-Peñalver, Berta
Jiménez-Abril, Jessica
Martínez-Hortelano, Alicia
Gil-Guillén, Vicente Francisco
Association between the HTR2C rs1414334 C/G gene polymorphism and the development of the metabolic syndrome in patients treated with atypical antipsychotics
title Association between the HTR2C rs1414334 C/G gene polymorphism and the development of the metabolic syndrome in patients treated with atypical antipsychotics
title_full Association between the HTR2C rs1414334 C/G gene polymorphism and the development of the metabolic syndrome in patients treated with atypical antipsychotics
title_fullStr Association between the HTR2C rs1414334 C/G gene polymorphism and the development of the metabolic syndrome in patients treated with atypical antipsychotics
title_full_unstemmed Association between the HTR2C rs1414334 C/G gene polymorphism and the development of the metabolic syndrome in patients treated with atypical antipsychotics
title_short Association between the HTR2C rs1414334 C/G gene polymorphism and the development of the metabolic syndrome in patients treated with atypical antipsychotics
title_sort association between the htr2c rs1414334 c/g gene polymorphism and the development of the metabolic syndrome in patients treated with atypical antipsychotics
topic Diabetes and Endocrinology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4941738/
https://www.ncbi.nlm.nih.gov/pubmed/27441116
http://dx.doi.org/10.7717/peerj.2163
work_keys_str_mv AT ricogomisjosemaria associationbetweenthehtr2crs1414334cggenepolymorphismandthedevelopmentofthemetabolicsyndromeinpatientstreatedwithatypicalantipsychotics
AT palazonbruantonio associationbetweenthehtr2crs1414334cggenepolymorphismandthedevelopmentofthemetabolicsyndromeinpatientstreatedwithatypicalantipsychotics
AT trianogarciairene associationbetweenthehtr2crs1414334cggenepolymorphismandthedevelopmentofthemetabolicsyndromeinpatientstreatedwithatypicalantipsychotics
AT mahechagarcialuisfabian associationbetweenthehtr2crs1414334cggenepolymorphismandthedevelopmentofthemetabolicsyndromeinpatientstreatedwithatypicalantipsychotics
AT garciamonsalveana associationbetweenthehtr2crs1414334cggenepolymorphismandthedevelopmentofthemetabolicsyndromeinpatientstreatedwithatypicalantipsychotics
AT navarroruizandres associationbetweenthehtr2crs1414334cggenepolymorphismandthedevelopmentofthemetabolicsyndromeinpatientstreatedwithatypicalantipsychotics
AT villagordopenalverberta associationbetweenthehtr2crs1414334cggenepolymorphismandthedevelopmentofthemetabolicsyndromeinpatientstreatedwithatypicalantipsychotics
AT jimenezabriljessica associationbetweenthehtr2crs1414334cggenepolymorphismandthedevelopmentofthemetabolicsyndromeinpatientstreatedwithatypicalantipsychotics
AT martinezhortelanoalicia associationbetweenthehtr2crs1414334cggenepolymorphismandthedevelopmentofthemetabolicsyndromeinpatientstreatedwithatypicalantipsychotics
AT gilguillenvicentefrancisco associationbetweenthehtr2crs1414334cggenepolymorphismandthedevelopmentofthemetabolicsyndromeinpatientstreatedwithatypicalantipsychotics